GT Biopharma Inc (GTBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Operating Expenses | 5,442 | 18,178 | 5,954 | 4,381 | 29,002 |
| Operating Income | -5,442 | -18,178 | -5,954 | -4,381 | -29,002 |
| Interest Expense | 0 | 22 | 0 | 0 | 696 |
| Other Income | 2 | 178 | 501 | -480 | 21 |
| Pre-tax Income | -5,440 | -18,022 | -5,453 | -4,861 | -29,677 |
| Net Income Continuous | -5,440 | -18,022 | -5,453 | -4,861 | -29,677 |
| Net Income | $-5,440 | $-18,022 | $-5,453 | $-4,861 | $-29,677 |
| EPS Basic Total Ops | -5.11 | 2.70 | -5.11 | -4.50 | -54.96 |
| EPS Basic Continuous Ops | -5.03 | 2.57 | -5.22 | -4.36 | -54.88 |
| EPS Diluted Total Ops | -5.11 | 2.70 | -5.11 | -4.50 | -54.96 |
| EPS Diluted Continuous Ops | -5.03 | 2.57 | -5.22 | -4.36 | -54.88 |
| EBITDA(a) | $-5,442 | $-18,178 | $-5,954 | $-4,381 | $-29,002 |